Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2026-03-10 @ 11:38 PM
Study NCT ID:
NCT03681093
Status:
COMPLETED
Last Update Posted:
2021-10-11
First Post:
2018-09-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Nasal Polyps | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Nasal Polyposis | View |
| None | Asthma | View |
| None | Nasal polyp score (NPS) | View |
| None | Nasal congestion score (NCS) | View |
| None | Bronchial Diseases | View |
| None | Lung Diseases | View |
| None | Nose Diseases | View |
| None | Respiratory Hypersensitivity | View |
| None | Fevipiprant | View |
| None | QAW039 | View |